ADVFN US – Market Content Editor
-
WTO report: AI could lift global trade by nearly 40% by 2040
Artificial intelligence (AI) has the potential to expand the value of international trade in goods and services by almost 40% by 2040, according to the World Trade Report 2025, released Wednesday by the World Trade Organization (WTO). The report outlines scenarios in which global trade grows between 34% and 37%, depending on the pace of…
-
Novo Nordisk targets full U.S. rollout of oral semaglutide in 2026
Novo Nordisk (NYSE:NVO) is planning a comprehensive launch of its oral semaglutide in the United States at the start of 2026, the company’s head of product and portfolio strategy confirmed on Wednesday. Speaking to Reuters, Products and Portfolio Strategy Chief Helfgott highlighted that the company sees a “very compelling offer” with its Wegovy pill compared…
-
China Orders Local Firms to Halt Purchases of Nvidia AI Chips
China’s internet regulator has instructed major domestic technology companies to stop buying chips from Nvidia (NASDAQ:NVDA), the semiconductor leader favored in artificial intelligence, according to the Financial Times. Sources familiar with the matter told the FT that firms including ByteDance, owner of TikTok, and e-commerce giant Alibaba were directed by the Cyberspace Administration of China…
-
Dollar Climbs from Two-Month Lows as Markets Await Fed Decision; Sterling Dips
The U.S. dollar gained slightly on Wednesday as investors positioned ahead of the Federal Reserve’s anticipated interest rate announcement, though it remained under pressure after recent losses. By 04:10 ET (08:10 GMT), the Dollar Index, which measures the greenback against six major currencies, was up 0.2% at 96.442, following a 0.7% drop on Tuesday that…
-
Incyte’s Povorcitinib Shows Promising Results in Hidradenitis Suppurativa Study
Incyte (NASDAQ:INCY) reported encouraging 24-week interim findings from its Phase 3 STOP-HS clinical trial program, evaluating povorcitinib, an oral JAK1 inhibitor, in adults with moderate to severe hidradenitis suppurativa (HS). The study revealed that patients treated with povorcitinib experienced clinically significant and meaningful improvements through Week 24. Almost 60% of participants in both povorcitinib groups…
-
Stellantis Issues Recall for Nearly 164,000 Jeep Vehicles Over Door Trim Concerns
Stellantis (NYSE:STLA) has announced a recall of close to 164,000 Jeep vehicles in the U.S. due to a possible detachment of door trim, the U.S. National Highway Traffic Safety Administration reported Wednesday. The recall covers select Chrysler Jeep Wagoneer and Jeep Grand Wagoneer models produced between 2022 and 2025. The defect involves trim on both…
-
GSK and Eli Lilly Join $350 Billion U.S. Drug Investment Wave Amid Tariff Concerns
GSK (NYSE:GSK) and Eli Lilly (NYSE:LLY) announced new investments in U.S. manufacturing on Tuesday, joining a growing number of global pharmaceutical companies expanding domestic capacity as the Trump administration weighs tariffs on imported medicines. The Wall Street Journal first reported the trend, noting that more than a dozen drugmakers have committed over $350 billion in…
-
Eli Lilly to Seek Global Approval for Experimental Weight-Loss Drug
Eli Lilly (NYSE:LLY) is preparing to file for regulatory approval of its investigational weight-loss medication, orforglipron, in several key markets in rapid succession, according to the company’s international president, Patrik Jonsson. “We are submitting to most of the major regulatory bodies pretty much at the same time,” Jonsson told Reuters. The filings will target authorities…
-
Crude Steadies Near Two-Week High as Fed Decision Looms
Oil prices held steady in Asian markets Wednesday after surging in recent sessions on concerns over potential disruptions to Russian supply, as traders awaited the outcome of the U.S. Federal Reserve’s policy meeting. Brent futures for November edged down to $68.39 a barrel, while West Texas Intermediate was at $64.09 a barrel (21:48 ET /…
-
Gold dips from record highs as markets await Fed guidance
Gold prices pulled back slightly in Wednesday’s early Asian trading, with investors cautious ahead of the U.S. Federal Reserve’s interest rate decision and policy outlook scheduled later in the day. Spot gold was down 0.4% at $3,673.38 per ounce by 02:40 ET (06:40 GMT), after reaching a historic high of $3,702.95 on Tuesday. U.S. December…